SlideShare a Scribd company logo
Chapter IV
Immunopharmacology
YEAR III Pharm.D
Dr. V. Chitra
The Immune Response - why and how ?
{ Discriminate: Self / Non self
{ Destroy:
z Infectious invaders
z Dysregulated self (cancers)
{ Immunity:
z Innate, Natural
z Adaptive, Learned
Who are involved ?
{ Innate
z Complement
z Granulocytes
z Monocytes/macrophages
z NK cells
z Mast cells
z Basophils
{ Adaptive:
z B and T
lymphocytes
z B: antibodies
z T : helper,
cytolytic,
suppressor.
IMMUNE MODIFIERS
Immunosuppressants Immunostimulants
? Immune tolerance
Immunosuppressants
{ Organ transplantation
{ Autoimmune diseases
{ Life long use
{ Infection, cancers
{ Nephrotoxicity
{ Diabetogenic
Problem
Immunosuppressants
{ Glucocorticoids
{ Calcineurin inhibitors
z Cyclosporine
z Tacrolimus
{ Antiproliferative / antimetabolic agents
z Sirolimus
z Everolimus
z Azathioprine
z Mycophenolate Mofetil
z Others – methotrexate, cyclophosphamide,
thalidomide and chlorambucil
{ Antibodies
z Antithymocyte globulin
z Anti CD3 monoclonal antibody
{ Muromonab
z Anti IL-2 receptor antibody –
{ Daclizumab, basiliximab
z Anti TNF alpha – infliximab, etanercept
Glucocorticoids
{ Induce redistribution of lymphocytes –
decrease in peripheral blood lymphocyte
counts
{ Intracellular receptors – regulate gene
transcription
{ Down regulation of IL-1, IL-6
{ Inhibition of T cell proliferation
{ Neutrophils, Monocytes display poor
chemotaxis
{ Broad anti-inflammatory effects on
multiple components of cellular immunity
USES - Glucocorticoids
{ Transplant rejection
{ GVH – BM transplantation
{ Autoimmune diseases – RA, SLE,
Hematological conditions
{ Psoriasis
{ Inflammatory Bowel Disease, Eye
conditions
Toxicity
{ Growth retardation
{ Avascular Necrosis of Bone
{ Risk of Infection
{ Poor wound healing
{ Cataract
{ Hyperglycemia
{ Hypertension
Calcineurin inhibitors
z Cyclosporine
z Tacrolimus
{ Most effective immunosuppressive
drugs
{ Target intracellular signaling
pathways
{ Blocks Induction of cytokine genes
Cyclosporine
{ More effective against T-cell dependent
immune mechanisms – transplant rejection,
autoimmunity
{ IV, Oral
Uses
{ Organ transplantation: Kidney, Liver, Heart
{ Rheumatoid arthritis, IBD, uveitis
{ Psoriasis
{ Aplastic anemia
{ Skin Conditions- Atopic dermatitis, Alopecia
Areata, Pemphigus vulgaris, Lichen planus,
Pyoderma gangrenosum
Toxicity : Cyclosporine
{ Renal dysfunction
{ Tremor
{ Hirsuitism
{ Hypertension
{ Hyperlipidemia
{ Gum hyperplasia
{ Hyperuricemia – worsens gout
{ Calcineurin inhibitors + Glucocorticoids =
Diabetogenic
Drug Interaction : Cyclosporine
{ CYP 3A4
z Inhibitors: CCB, Antifungals,
Antibiotics, HIV PI, Grape juice
z Inducers: Rifampicin, Phenytoin
{ Additive nephrotoxicity: NSAIDs
Tacrolimus
{ Inhibits T-cell activation by
inhibiting calcineurin
{ Use
z Prophylaxis of solid-organ allograft
rejection
Toxicity - Tacrolimus
{ Nephrotoxicity
{ Neurotoxicity-Tremor, headache, motor
disturbances, seizures
{ GI Complaints
{ Hypertension
{ Hyperglycemia
{ Risk of tumors, infections
{ Drug interaction
z Synergistic nephrotoxicity with cyclosporine
z CYP3A4
Antiproliferative and Antimetabolic
drugs
{ Sirolimus
{ Everolimus
{ Azathioprine
{ Mycophenolate Mofetil
{ Others:
z Methotrexate
z Cyclophosphamide
z Thalidomide
z Chlorambucil
Sirolimus
{ Inhibits T-cell activation and
Proliferation
{ Complexes with an immunophilin,
Inhibits a key enzyme in cell cycle
progression – mammalian target of
rapamycin (mTOR)
Sirolimus
Uses
{ Prophylaxis of organ transplant rejection
along with other drugs
Toxicity
{ Increase in serum cholesterol, Triglycerides
{ Anemia
{ Thrombocytopenia
{ Hypokalemia
{ Fever
{ GI effects
{ Risk of infection, tumors
{ Drug Interactions: CYP 3A4
Everolimus
{ Shorter half life compared to
sirolimus
{ Shorter time taken to reach steady
state
{ Similar toxicity, drug interactions
Azathioprine
{ Purine antimetabolite
{ Incorporation of false nucleotide
6 Thio-IMP 6Thio-GMP 6Thio-GTP
{ Inhibition of cell proliferation
{ Impairment of lymphocyte function
Uses
{ Prevention of organ transplant
rejection
{ Rheumatoid arthritis
Toxicity - Azathioprine
{ Bone marrow suppression-
leukopenia, thrombocytopenia,
anemia
{ Increased susceptibility to infection
{ Hepatotoxicity
{ Alopecia
{ GI toxicity
{ Drug interaction: Allopurinol
Mycophenolate Mofetil
{ Prodrug Æ Mycophenolic acid
{ Inhibits IMPDH – enzyme in guanine
synthesis
{ T, B cells are highly dependent on
this pathway for cell proliferation
{ Selectively inhibits lymphocyte
proliferation, function – Antibody
formation, cellular adhesion,
migration
Uses - Mycophenolate Mofetil
{ Prophylaxis of transplant rejection
{ Combination: Glucocorticoids
Calcineurin Inhibitors
{ Toxicity
{ GI, Hematological
z Diarrhea, Leucopenia
{ Risk of Infection
Drug Interaction
{ Decreased absorption when co-
administered with antacids
{ Acyclovir, Gancyclovir compete with
mycophenolate for tubular secretion
FTY720
{ S1P-R agonist – sphingosine 1 receptor
{ Reduce recirculation of lymphocytes from
lymphatic system to blood and peripheral
tissues
{ “Lymphocyte homing” – periphery into
lymph node
{ Protects graft from T-cell-mediated attack
Uses
{ Combination immunosuppression therapy
in prevention of acute graft rejection
Toxicity
{ Lymphopenia
{ Negative chronotropic effect
z S1P-receptor on human atrial myocytes
Antibodies
{ Against
lymphocyte cell-
surface antigens
{ Polyclonal /
Monoclonal
Antibodies
{ Antithymocyte Globulin
{ Monoclonal antibodies
z Anti-CD3 Monoclonal antibody (Muromonab-CD3)
z Anti-IL-2 Receptor antibody (Daclizumab,
Basiliximab)
z Campath-1H (Alemtuzumab)
{ Anti-TNF Agents
z Infliximab
z Etanercept
z Adalimumab
{ LFA-1 Inhibitor (lymphocyte function associated)
z Efalizumab
Anti-thymocyte Globulin
{ Purified gamma globulin from serum of
rabbits immunized with human thymocytes
{ Cytotoxic to lymphocytes & block lymphocyte
function
Uses
{ Induction of immunosuppression –
transplantation
{ Treatment of acute transplant rejection
Toxicity
{ Hypersensitivity
{ Risk of infection, Malignancy
Anti-CD3 Monoclonal Antibody
{ Muromonab-CD3
{ Binds to CD3, a component of T-cell
receptor complex involved in
z antigen recognition
z cell signaling & proliferation
Muromonab-CD3
Antibody treatment
Rapid internalization of T-cell
receptor
Prevents subsequent antigen
recognition
Uses
{ Treatment of acute organ transplant
rejection
Toxicity
{ “Cytokine release syndrome”
{ High fever, Chills, Headache,
Tremor, myalgia, arthralgia,
weakness
{ Prevention: Steroids
Anti-IL-2 Receptor Antibodies
{ Daclizumab and Basiliximab
{ Bind to IL-2 receptor on surface of
activated T cells Æ Block IL-2 mediated
T-cell activation
Uses
{ Prophylaxis of Acute organ rejection
Toxicity
{ Anaphylaxis, Opportunistic Infections
Campath-1H (Alemtuzumab)
{ Targets CD52 – expressed on
lymphocytes, monocytes, Macrophages
{ Extensive lympholysis – Prolonged T &
B cell depletion
Uses
{ Renal transplantation
Anti-TNF Agents
{ TNF – Cytokine at site of inflammation
{ Infliximab
{ Etanercept
{ Adalimumab
Infliximab
Uses
{ Rheumatoid arthritis
{ Chron’s disease – fistulae
{ Psoriasis
{ Psoriatic arthritis
{ Ankylosing spondylosis
Toxicity
{ Infusion reaction – fever, urticaria,
hypotension, dyspnoea
{ Opportunistic infections – TB, RTI, UTI
Etanercept
{ Fusion protein
{ Ligand binding portion of Human TNF-α
receptor fused to Fc portion of human
IgG1
Uses
{ Rheumatoid arthritis
Moderate to severely active crohn’s disease
Adalimumab
Recombinant human anti-TNF mAb
LFA-1 Inhibitor - Efalizumab
{ Monoclonal Ab Targeting
Lymphocyte Function Associated
Antigen
{ Blocks T-cell Adhesion, Activation,
Trafficking
Uses
{ Organ transplantation
{ Psoriasis
Sites of Action of Selected Immunosuppressive Agents on
T-Cell Activation
DRUG SITE OF ACTION
{ Glucocorticoids Glucocorticoid response elements in
DNA (regulate gene transcription)
{ Muromonab- CD3T-cell receptor complex (blocks
antigen recognition)
{ Cyclosporine Calcineurin (inhibits phosphatase
activity)
{ Tacrolimus Calcineurin (inhibits phosphatase
activity)
{ Azathioprine Deoxyribonucleic acid (false
nucleotide incorporation)
{ Mycophenolate Mofetil Inosine monophosphate
dehydrogenase (inhibits activity)
{ Daclizumab, Basiliximab IL-2 receptor (block IL-2-mediated
T-cell activation)
{ Sirolimus Protein kinase involved in cell-cycle
progression (mTOR) (inhibits
activity)
Immunostimulants
{ Levamisole
{ Thalidomide
{ BCG
{ Recombinant Cytokines
z Interferons
z Interleukin-2
Levamisole
{ Antihelminthic
{ Restores depressed immune
function of B, T cells, Monocytes,
Macrophages
{ Adjuvant therapy with 5FU in colon
cancer
Toxicity
{ Agranulocytosis
Thalidomide
{ Birth defect
{ Contraindicated in women with
childbearing potential
{ Enhanced T-cell production of
cytokines – IL-2, IFN-γ
{ NK cell-mediated cytotoxicity against
tumor cells
USE:
{ Multiple myeloma
Bacillus Calmette-Guerin
{ Live, attenuated culture of BCG
strain of Mycobacterium Bovis
{ Carcinoma Bladder
Adverse Effects
z Hypersensitivity
z Shock
z Chills
Interferons
{ Antiviral
{ Immunomodulatory activity
{ Bind to cell surface receptors –
initiate intracellular events
z Enzyme induction
z Inhibition of cell proliferation
z Enhancement of immune activities
z Increased Phagocytosis
Interferon alpha-2b
{ Hairy cell leukemia
{ Malignant melanoma
{ Kaposi sarcoma
{ Hepatitis B
Adverse reactions
{ Flu-like symptoms – fever, chills,
headache
{ CVS- hypotension, Arrhythmia
{ CNS- depression, confusion
Interleukin-2 (aldesleukin)
{ Proliferation of cellular immunity –
Lymphocytosis, eosinophilia, release of
multiple cytokines – TNF, IL-1, IFN-γ
Uses
{ Metastatic renal cell carcinoma
{ Melanoma
{ Toxicity
{ Cardiovascular: capillary leak syndrome,
Hypotension
Immunization
{ Vaccines
{ Immune Globulin
{ Rho (D) Immune
Globulin
Immunization
{ Active – Stimulation with an Antigen
{ Passive – Preformed antibody
Active immunization
Vaccines
{ Administration of antigen as a
whole, killed organism, or a specific
protein or peptide constituent of an
organism
{ Booster doses
{ Anticancer vaccines – immunizing
patients with APCs expressing
tumor antigen.
Immune Globulin
Indications
{ Individual is deficient in antibodies
– immunodeficiency
{ Individual is exposed to an agent,
inadequate time for active
immunization
z Rabies
z Hepatitis B
{ Nonspecific immunoglobulins
z Antibody-deficiency disorders
{ Specific immune globulins
z High titers of desired antibody
z Hepatitis B, Rabies, Tetanus
Rho (D) Immune Globulin
{ Antibodies against Rh(D)
antigen on the surface of
RBC
{ Rh-negative women may be
sensitized to “Foreign” Rh
antigen on fetal RBC
{ Anti-RH Antibodies
produced in mother can
damage subsequent fetuses
by lysing RBC’s
{ Hemolytic disease of
newborn

More Related Content

Similar to Immunopharmacology.pdf

Immunosupressants
Immunosupressants Immunosupressants
Immunosupressants
Sanju Kaladharan
 
Immunostimulants & immunosuppressants
Immunostimulants & immunosuppressantsImmunostimulants & immunosuppressants
Immunostimulants & immunosuppressants
NiraliThakkar20
 
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...European School of Oncology
 
PH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptxPH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptx
Dr-Mani Bharti
 
Monoclonal antibodies in cancer therapy
Monoclonal antibodies in cancer therapy Monoclonal antibodies in cancer therapy
Monoclonal antibodies in cancer therapy
SameerKhasbage
 
Immunosuppressant drugs
Immunosuppressant drugsImmunosuppressant drugs
Immunosuppressant drugs
THUSHARA MOHAN
 
Immunosuppressants
ImmunosuppressantsImmunosuppressants
Immunosuppressants
Shyam Doiphode Patil
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. PosadaMedicineAndHealthCancer
 
Immunosuppressants [autosaved]
Immunosuppressants [autosaved]Immunosuppressants [autosaved]
Immunosuppressants [autosaved]B.Devadatha datha
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapyEltaib Ali
 
IMMUNOSUPPRESSANT DRUGS
IMMUNOSUPPRESSANT DRUGSIMMUNOSUPPRESSANT DRUGS
IMMUNOSUPPRESSANT DRUGS
paramesh Researcher
 
Biologicals in Dermatology (Part 2)
Biologicals in Dermatology (Part 2)Biologicals in Dermatology (Part 2)
Biologicals in Dermatology (Part 2)
Smruti Ramawanshi
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
Dr. Dheeraj Mulchandani
 
Immunomodulators and their application as adjuvant
Immunomodulators and their application as adjuvantImmunomodulators and their application as adjuvant
Immunomodulators and their application as adjuvant
Ankita Gurao
 
Immunosuppresants
ImmunosuppresantsImmunosuppresants
Immunosuppresants
Aditya Singh
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
swarnank parmar
 
Chemotherapy 101
Chemotherapy 101Chemotherapy 101
Chemotherapy 101derosaMSKCC
 
INDUCTION PPT.pptx
INDUCTION PPT.pptxINDUCTION PPT.pptx
INDUCTION PPT.pptx
twiztidme
 
En docrine changes with immune therapy1
En docrine changes with immune therapy1En docrine changes with immune therapy1
En docrine changes with immune therapy1Rajasree nambron
 

Similar to Immunopharmacology.pdf (20)

Immunosupressants
Immunosupressants Immunosupressants
Immunosupressants
 
Immunostimulants & immunosuppressants
Immunostimulants & immunosuppressantsImmunostimulants & immunosuppressants
Immunostimulants & immunosuppressants
 
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
 
PH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptxPH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptx
 
Monoclonal antibodies in cancer therapy
Monoclonal antibodies in cancer therapy Monoclonal antibodies in cancer therapy
Monoclonal antibodies in cancer therapy
 
Immunosuppressant drugs
Immunosuppressant drugsImmunosuppressant drugs
Immunosuppressant drugs
 
Immunosuppressants
ImmunosuppressantsImmunosuppressants
Immunosuppressants
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. Posada
 
Immunosuppressants [autosaved]
Immunosuppressants [autosaved]Immunosuppressants [autosaved]
Immunosuppressants [autosaved]
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
IMMUNOSUPPRESSANT DRUGS
IMMUNOSUPPRESSANT DRUGSIMMUNOSUPPRESSANT DRUGS
IMMUNOSUPPRESSANT DRUGS
 
Biologicals in Dermatology (Part 2)
Biologicals in Dermatology (Part 2)Biologicals in Dermatology (Part 2)
Biologicals in Dermatology (Part 2)
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Immunomodulators and their application as adjuvant
Immunomodulators and their application as adjuvantImmunomodulators and their application as adjuvant
Immunomodulators and their application as adjuvant
 
Immunosuppresants
ImmunosuppresantsImmunosuppresants
Immunosuppresants
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Chemotherapy 101
Chemotherapy 101Chemotherapy 101
Chemotherapy 101
 
INDUCTION PPT.pptx
INDUCTION PPT.pptxINDUCTION PPT.pptx
INDUCTION PPT.pptx
 
En docrine changes with immune therapy1
En docrine changes with immune therapy1En docrine changes with immune therapy1
En docrine changes with immune therapy1
 

More from petshelter54

Week6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formationWeek6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formation
petshelter54
 
white blood cell.ppt general classification of lymphocytes
white blood cell.ppt general classification of lymphocyteswhite blood cell.ppt general classification of lymphocytes
white blood cell.ppt general classification of lymphocytes
petshelter54
 
HYPERSENSITIVITY 204. and the immune system
HYPERSENSITIVITY 204. and the immune systemHYPERSENSITIVITY 204. and the immune system
HYPERSENSITIVITY 204. and the immune system
petshelter54
 
INTRO Physiology and history of physiology
INTRO Physiology and history of physiologyINTRO Physiology and history of physiology
INTRO Physiology and history of physiology
petshelter54
 
Com 201 - Intro to Demography and biostatistics
Com 201 - Intro to Demography and biostatisticsCom 201 - Intro to Demography and biostatistics
Com 201 - Intro to Demography and biostatistics
petshelter54
 
business environment and work environment for entrepreneurs
business environment and work environment for entrepreneursbusiness environment and work environment for entrepreneurs
business environment and work environment for entrepreneurs
petshelter54
 
BCM 201_Energetics of life and the functioning of living organisms
BCM 201_Energetics of life and the functioning of living organismsBCM 201_Energetics of life and the functioning of living organisms
BCM 201_Energetics of life and the functioning of living organisms
petshelter54
 
2b. Membrane Potentials n Excitable Tissues - PPT.pptx
2b. Membrane Potentials n Excitable Tissues - PPT.pptx2b. Membrane Potentials n Excitable Tissues - PPT.pptx
2b. Membrane Potentials n Excitable Tissues - PPT.pptx
petshelter54
 

More from petshelter54 (8)

Week6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formationWeek6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formation
 
white blood cell.ppt general classification of lymphocytes
white blood cell.ppt general classification of lymphocyteswhite blood cell.ppt general classification of lymphocytes
white blood cell.ppt general classification of lymphocytes
 
HYPERSENSITIVITY 204. and the immune system
HYPERSENSITIVITY 204. and the immune systemHYPERSENSITIVITY 204. and the immune system
HYPERSENSITIVITY 204. and the immune system
 
INTRO Physiology and history of physiology
INTRO Physiology and history of physiologyINTRO Physiology and history of physiology
INTRO Physiology and history of physiology
 
Com 201 - Intro to Demography and biostatistics
Com 201 - Intro to Demography and biostatisticsCom 201 - Intro to Demography and biostatistics
Com 201 - Intro to Demography and biostatistics
 
business environment and work environment for entrepreneurs
business environment and work environment for entrepreneursbusiness environment and work environment for entrepreneurs
business environment and work environment for entrepreneurs
 
BCM 201_Energetics of life and the functioning of living organisms
BCM 201_Energetics of life and the functioning of living organismsBCM 201_Energetics of life and the functioning of living organisms
BCM 201_Energetics of life and the functioning of living organisms
 
2b. Membrane Potentials n Excitable Tissues - PPT.pptx
2b. Membrane Potentials n Excitable Tissues - PPT.pptx2b. Membrane Potentials n Excitable Tissues - PPT.pptx
2b. Membrane Potentials n Excitable Tissues - PPT.pptx
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 

Immunopharmacology.pdf

  • 2. The Immune Response - why and how ? { Discriminate: Self / Non self { Destroy: z Infectious invaders z Dysregulated self (cancers) { Immunity: z Innate, Natural z Adaptive, Learned
  • 3. Who are involved ? { Innate z Complement z Granulocytes z Monocytes/macrophages z NK cells z Mast cells z Basophils { Adaptive: z B and T lymphocytes z B: antibodies z T : helper, cytolytic, suppressor.
  • 4.
  • 6. Immunosuppressants { Organ transplantation { Autoimmune diseases { Life long use { Infection, cancers { Nephrotoxicity { Diabetogenic Problem
  • 7. Immunosuppressants { Glucocorticoids { Calcineurin inhibitors z Cyclosporine z Tacrolimus { Antiproliferative / antimetabolic agents z Sirolimus z Everolimus z Azathioprine z Mycophenolate Mofetil z Others – methotrexate, cyclophosphamide, thalidomide and chlorambucil
  • 8. { Antibodies z Antithymocyte globulin z Anti CD3 monoclonal antibody { Muromonab z Anti IL-2 receptor antibody – { Daclizumab, basiliximab z Anti TNF alpha – infliximab, etanercept
  • 9. Glucocorticoids { Induce redistribution of lymphocytes – decrease in peripheral blood lymphocyte counts { Intracellular receptors – regulate gene transcription { Down regulation of IL-1, IL-6 { Inhibition of T cell proliferation { Neutrophils, Monocytes display poor chemotaxis { Broad anti-inflammatory effects on multiple components of cellular immunity
  • 10. USES - Glucocorticoids { Transplant rejection { GVH – BM transplantation { Autoimmune diseases – RA, SLE, Hematological conditions { Psoriasis { Inflammatory Bowel Disease, Eye conditions
  • 11. Toxicity { Growth retardation { Avascular Necrosis of Bone { Risk of Infection { Poor wound healing { Cataract { Hyperglycemia { Hypertension
  • 12. Calcineurin inhibitors z Cyclosporine z Tacrolimus { Most effective immunosuppressive drugs { Target intracellular signaling pathways { Blocks Induction of cytokine genes
  • 13.
  • 14. Cyclosporine { More effective against T-cell dependent immune mechanisms – transplant rejection, autoimmunity { IV, Oral Uses { Organ transplantation: Kidney, Liver, Heart { Rheumatoid arthritis, IBD, uveitis { Psoriasis { Aplastic anemia { Skin Conditions- Atopic dermatitis, Alopecia Areata, Pemphigus vulgaris, Lichen planus, Pyoderma gangrenosum
  • 15. Toxicity : Cyclosporine { Renal dysfunction { Tremor { Hirsuitism { Hypertension { Hyperlipidemia { Gum hyperplasia { Hyperuricemia – worsens gout { Calcineurin inhibitors + Glucocorticoids = Diabetogenic
  • 16. Drug Interaction : Cyclosporine { CYP 3A4 z Inhibitors: CCB, Antifungals, Antibiotics, HIV PI, Grape juice z Inducers: Rifampicin, Phenytoin { Additive nephrotoxicity: NSAIDs
  • 17. Tacrolimus { Inhibits T-cell activation by inhibiting calcineurin { Use z Prophylaxis of solid-organ allograft rejection
  • 18. Toxicity - Tacrolimus { Nephrotoxicity { Neurotoxicity-Tremor, headache, motor disturbances, seizures { GI Complaints { Hypertension { Hyperglycemia { Risk of tumors, infections { Drug interaction z Synergistic nephrotoxicity with cyclosporine z CYP3A4
  • 19. Antiproliferative and Antimetabolic drugs { Sirolimus { Everolimus { Azathioprine { Mycophenolate Mofetil { Others: z Methotrexate z Cyclophosphamide z Thalidomide z Chlorambucil
  • 20. Sirolimus { Inhibits T-cell activation and Proliferation { Complexes with an immunophilin, Inhibits a key enzyme in cell cycle progression – mammalian target of rapamycin (mTOR)
  • 21.
  • 22. Sirolimus Uses { Prophylaxis of organ transplant rejection along with other drugs Toxicity { Increase in serum cholesterol, Triglycerides { Anemia { Thrombocytopenia { Hypokalemia { Fever { GI effects { Risk of infection, tumors { Drug Interactions: CYP 3A4
  • 23. Everolimus { Shorter half life compared to sirolimus { Shorter time taken to reach steady state { Similar toxicity, drug interactions
  • 24. Azathioprine { Purine antimetabolite { Incorporation of false nucleotide 6 Thio-IMP 6Thio-GMP 6Thio-GTP { Inhibition of cell proliferation { Impairment of lymphocyte function Uses { Prevention of organ transplant rejection { Rheumatoid arthritis
  • 25. Toxicity - Azathioprine { Bone marrow suppression- leukopenia, thrombocytopenia, anemia { Increased susceptibility to infection { Hepatotoxicity { Alopecia { GI toxicity { Drug interaction: Allopurinol
  • 26. Mycophenolate Mofetil { Prodrug Æ Mycophenolic acid { Inhibits IMPDH – enzyme in guanine synthesis { T, B cells are highly dependent on this pathway for cell proliferation { Selectively inhibits lymphocyte proliferation, function – Antibody formation, cellular adhesion, migration
  • 27. Uses - Mycophenolate Mofetil { Prophylaxis of transplant rejection { Combination: Glucocorticoids Calcineurin Inhibitors { Toxicity { GI, Hematological z Diarrhea, Leucopenia { Risk of Infection
  • 28. Drug Interaction { Decreased absorption when co- administered with antacids { Acyclovir, Gancyclovir compete with mycophenolate for tubular secretion
  • 29. FTY720 { S1P-R agonist – sphingosine 1 receptor { Reduce recirculation of lymphocytes from lymphatic system to blood and peripheral tissues { “Lymphocyte homing” – periphery into lymph node { Protects graft from T-cell-mediated attack Uses { Combination immunosuppression therapy in prevention of acute graft rejection
  • 30. Toxicity { Lymphopenia { Negative chronotropic effect z S1P-receptor on human atrial myocytes
  • 31. Antibodies { Against lymphocyte cell- surface antigens { Polyclonal / Monoclonal
  • 32. Antibodies { Antithymocyte Globulin { Monoclonal antibodies z Anti-CD3 Monoclonal antibody (Muromonab-CD3) z Anti-IL-2 Receptor antibody (Daclizumab, Basiliximab) z Campath-1H (Alemtuzumab) { Anti-TNF Agents z Infliximab z Etanercept z Adalimumab { LFA-1 Inhibitor (lymphocyte function associated) z Efalizumab
  • 33. Anti-thymocyte Globulin { Purified gamma globulin from serum of rabbits immunized with human thymocytes { Cytotoxic to lymphocytes & block lymphocyte function Uses { Induction of immunosuppression – transplantation { Treatment of acute transplant rejection Toxicity { Hypersensitivity { Risk of infection, Malignancy
  • 34. Anti-CD3 Monoclonal Antibody { Muromonab-CD3 { Binds to CD3, a component of T-cell receptor complex involved in z antigen recognition z cell signaling & proliferation
  • 35. Muromonab-CD3 Antibody treatment Rapid internalization of T-cell receptor Prevents subsequent antigen recognition
  • 36. Uses { Treatment of acute organ transplant rejection Toxicity { “Cytokine release syndrome” { High fever, Chills, Headache, Tremor, myalgia, arthralgia, weakness { Prevention: Steroids
  • 37. Anti-IL-2 Receptor Antibodies { Daclizumab and Basiliximab { Bind to IL-2 receptor on surface of activated T cells Æ Block IL-2 mediated T-cell activation Uses { Prophylaxis of Acute organ rejection Toxicity { Anaphylaxis, Opportunistic Infections
  • 38. Campath-1H (Alemtuzumab) { Targets CD52 – expressed on lymphocytes, monocytes, Macrophages { Extensive lympholysis – Prolonged T & B cell depletion Uses { Renal transplantation
  • 39. Anti-TNF Agents { TNF – Cytokine at site of inflammation { Infliximab { Etanercept { Adalimumab
  • 40.
  • 41.
  • 42. Infliximab Uses { Rheumatoid arthritis { Chron’s disease – fistulae { Psoriasis { Psoriatic arthritis { Ankylosing spondylosis Toxicity { Infusion reaction – fever, urticaria, hypotension, dyspnoea { Opportunistic infections – TB, RTI, UTI
  • 43. Etanercept { Fusion protein { Ligand binding portion of Human TNF-α receptor fused to Fc portion of human IgG1 Uses { Rheumatoid arthritis
  • 44.
  • 45. Moderate to severely active crohn’s disease Adalimumab Recombinant human anti-TNF mAb
  • 46. LFA-1 Inhibitor - Efalizumab { Monoclonal Ab Targeting Lymphocyte Function Associated Antigen { Blocks T-cell Adhesion, Activation, Trafficking Uses { Organ transplantation { Psoriasis
  • 47. Sites of Action of Selected Immunosuppressive Agents on T-Cell Activation DRUG SITE OF ACTION { Glucocorticoids Glucocorticoid response elements in DNA (regulate gene transcription) { Muromonab- CD3T-cell receptor complex (blocks antigen recognition) { Cyclosporine Calcineurin (inhibits phosphatase activity) { Tacrolimus Calcineurin (inhibits phosphatase activity) { Azathioprine Deoxyribonucleic acid (false nucleotide incorporation) { Mycophenolate Mofetil Inosine monophosphate dehydrogenase (inhibits activity) { Daclizumab, Basiliximab IL-2 receptor (block IL-2-mediated T-cell activation) { Sirolimus Protein kinase involved in cell-cycle progression (mTOR) (inhibits activity)
  • 48. Immunostimulants { Levamisole { Thalidomide { BCG { Recombinant Cytokines z Interferons z Interleukin-2
  • 49. Levamisole { Antihelminthic { Restores depressed immune function of B, T cells, Monocytes, Macrophages { Adjuvant therapy with 5FU in colon cancer Toxicity { Agranulocytosis
  • 50. Thalidomide { Birth defect { Contraindicated in women with childbearing potential { Enhanced T-cell production of cytokines – IL-2, IFN-γ { NK cell-mediated cytotoxicity against tumor cells USE: { Multiple myeloma
  • 51. Bacillus Calmette-Guerin { Live, attenuated culture of BCG strain of Mycobacterium Bovis { Carcinoma Bladder Adverse Effects z Hypersensitivity z Shock z Chills
  • 52. Interferons { Antiviral { Immunomodulatory activity { Bind to cell surface receptors – initiate intracellular events z Enzyme induction z Inhibition of cell proliferation z Enhancement of immune activities z Increased Phagocytosis
  • 53. Interferon alpha-2b { Hairy cell leukemia { Malignant melanoma { Kaposi sarcoma { Hepatitis B Adverse reactions { Flu-like symptoms – fever, chills, headache { CVS- hypotension, Arrhythmia { CNS- depression, confusion
  • 54. Interleukin-2 (aldesleukin) { Proliferation of cellular immunity – Lymphocytosis, eosinophilia, release of multiple cytokines – TNF, IL-1, IFN-γ Uses { Metastatic renal cell carcinoma { Melanoma { Toxicity { Cardiovascular: capillary leak syndrome, Hypotension
  • 55. Immunization { Vaccines { Immune Globulin { Rho (D) Immune Globulin
  • 56. Immunization { Active – Stimulation with an Antigen { Passive – Preformed antibody
  • 57.
  • 58. Active immunization Vaccines { Administration of antigen as a whole, killed organism, or a specific protein or peptide constituent of an organism { Booster doses { Anticancer vaccines – immunizing patients with APCs expressing tumor antigen.
  • 59. Immune Globulin Indications { Individual is deficient in antibodies – immunodeficiency { Individual is exposed to an agent, inadequate time for active immunization z Rabies z Hepatitis B
  • 60. { Nonspecific immunoglobulins z Antibody-deficiency disorders { Specific immune globulins z High titers of desired antibody z Hepatitis B, Rabies, Tetanus
  • 61. Rho (D) Immune Globulin { Antibodies against Rh(D) antigen on the surface of RBC { Rh-negative women may be sensitized to “Foreign” Rh antigen on fetal RBC { Anti-RH Antibodies produced in mother can damage subsequent fetuses by lysing RBC’s { Hemolytic disease of newborn